![[Industry Direct] PHI Studio & Agog Are Seeking Immersive Artists for a Four Week Residency Program](https://roadtovrlive-5ea0.kxcdn.com/wp-content/uploads/2025/05/phi-immersive-residency-2-341x220.jpg?#)
J&J eye disease gene therapy bota-vec fails Phase 3
Johnson & Johnson’s gene therapy for a genetic disease that leads to vision loss called X-linked retinitis pigmentosa (XLRP) failed a pivotal trial, according to an update to a J&J healthcare provider website. At one ...
Johnson & Johnson’s gene therapy for a genetic disease that leads to vision loss called X-linked retinitis pigmentosa (XLRP) failed a pivotal trial, according to an update to a J&J healthcare provider website.
At one ...
